Members |
targetComponentId |
Lymphadenopathy |
Lymphadenopathy |
Lymphadenopathy |
Lymphadenopathy |
Lymphatic incision |
Incision of lymphatic system structure |
Lymphatic incision |
Incision of lymphatic system structure |
Lymphatic of lower extremity |
Structure of lymphatic vessel of lower limb (body structure) |
Lymphatic system surgical procedure |
Operation on lymphatic structure |
Lymphatic vessel tumor |
Lymphatic vessel tumor |
Lymphedema of face |
Lymphoedema of face |
Lymphocyte antibody |
Anti lymphocyte antibody |
Lymphocyte antigen CD13 |
Lymphocyte antigen CD13 |
Lymphocyte antigen CD26 |
Dipeptidyl peptidase IV |
Lymphocyte antigen CD35 |
Complement receptor CRI |
Lymphocyte antigen CD52 |
Lymphocyte antigen CDw52 |
Lymphocyte antigen CD55 |
Decay accelerating factor |
Lymphocyte antigen CD62P |
Lymphocyte antigen CD62 |
Lymphocyte antigen CD66B |
Lymphocyte antigen CD67 |
Lymphocyte antigen CD66E |
Carcinoembryonic antigen |
Lymphocyte antigen CDw29 |
Cluster of differentiation antigen 29 |
Lymphocyte count |
Lymphocyte count |
Lymphocyte count abnormal |
Lymphocyte count outside reference range (finding) |
Lymphocyte count normal |
Lymphocyte count within reference range |
Lymphocyte positive for both CD16 antigen and CD56 antigen and negative for CD3 antigen |
Lymphocyte negative for CD3 antigen and positive for both CD16 antigen and CD56 antigen (cell) |
Lymphocyte proliferation test |
Lymphocyte proliferation test |
Lymphocytic thyroiditis - autoimmune |
Hashimoto thyroiditis |
Lymphocytosis - absolute |
Lymphocytosis - absolute (disorder) |
Lymphoepithelioid lymphoma |
Lymphoepithelioid lymphoma (clinical) |
Lymphogranuloma venereum antigen skin test |
Lymphogranuloma venereum antigen skin test |
Lymphoid aggregate |
Structure of aggregated lymphoid follicle of small intestine |
Lymphoid aggregate |
Structure of aggregated lymphoid follicle of small intestine |
Lymphoma stage I |
Lymphoma stage I |
Lymphoma stage I |
Lymphoma stage I |
Lymphoma stage I |
Lymphoma stage I |
Lymphoma stage II |
Lymphoma stage II |
Lymphoma stage II |
Lymphoma stage II |
Lymphoma stage II |
Lymphoma stage II |
Lymphoma stage III |
Lymphoma stage III |
Lymphoma stage III |
Lymphoma stage III |
Lymphoma stage III |
Lymphoma stage III |
Lymphoma stage IV |
Lymphoma stage IV |
Lymphoma stage IV |
Lymphoma stage IV |
Lymphoma stage IV |
Lymphoma stage IV |
Lymphoma staging system |
Staging classification for lymphoma |
Lymphoma staging system |
Staging classification for lymphoma |
Lymphoma staging system |
Staging classification for lymphoma |
Lymphoma, nodular or follicular |
Malignant lymphoma, follicular AND/OR nodular (morphologic abnormality) |
Lymphomatoid granulomatosis of lung |
Lymphomatoid granulomatosis of lung (disorder) |
Lymphomatoid papulosis |
Lymphomatoid papulosis |
Lymphosarcoma |
Lymphosarcoma |
Lymphotoxin |
Tumor necrosis factor beta |
Lyre-tailed nightjar |
Uropsalis lyra (organism) |
Lysinibacillus manganicus |
Ureibacillus manganicus (organism) |
Lysinuric protein intolerance |
Lysinuric protein intolerance |
Lysinuric protein intolerance |
Lysinuric protein intolerance |
Lysinuric protein intolerance |
Lysinuric protein intolerance |
Lysis |
Lysis (morphologic abnormality) |
Lysosomal alpha-1,4-glucosidase deficiency |
A rare lysosomal storage disease characterized by lysosomal accumulation of glycogen particularly in skeletal, cardiac, and respiratory muscles, as well as the liver and nervous system, due to acid maltase deficiency. The clinical spectrum comprises infantile-onset disease with severe hypertrophic cardiomyopathy, generalized muscle weakness, poor feeding and failure to thrive, and respiratory insufficiency, and late-onset disease manifesting before or after twelve months of age without cardiomyopathy, with proximal muscle weakness and respiratory insufficiency. |
Lysosomal alpha-1,4-glucosidase deficiency - adult onset |
Glycogen storage disease due to acid maltase deficiency, late onset (AMDL), a form of Glycogen storage disease due to acid maltase deficiency (AMD), a degenerative metabolic myopathy particularly affecting respiratory and skeletal muscles, is characterized by an accumulation of glycogen in lysosomes. |
Lysosomal alpha-1,4-glucosidase deficiency - infantile onset |
A rare lysosomal storage disease characterized by lysosomal accumulation of glycogen particularly in skeletal, cardiac, and respiratory muscles, as well as the liver and nervous system, due to acid maltase deficiency. The clinical spectrum comprises infantile-onset disease with severe hypertrophic cardiomyopathy, generalized muscle weakness, poor feeding and failure to thrive, and respiratory insufficiency, and late-onset disease manifesting before or after twelve months of age without cardiomyopathy, with proximal muscle weakness and respiratory insufficiency. |
Lysosomal alpha-1,4-glucosidase deficiency - juvenile onset |
Glycogen storage disease due to acid maltase deficiency, late onset (AMDL), a form of Glycogen storage disease due to acid maltase deficiency (AMD), a degenerative metabolic myopathy particularly affecting respiratory and skeletal muscles, is characterized by an accumulation of glycogen in lysosomes. |
Lysozyme |
Lysozyme |
Lysuride overdose of undetermined intent |
Lysuride overdose |
Lysuride poisoning of undetermined intent |
Lysuride poisoning (disorder) |
M.E.Association member |
M.E.Association member |
M2 mitochondrial antibody (EIA) level |
M2 mitochondrial antibody (EIA) level |
M2 mitochondrial antibody (EIA) level |
M2 mitochondrial antibody (EIA) level |
M4 mitochondrial antibody (EIA) level |
M4 mitochondrial antibody (EIA) level |
M4 mitochondrial antibody (EIA) level |
M4 mitochondrial antibody (EIA) level |
M9 mitochondrial antibody (EIA) level |
M9 mitochondrial antibody (EIA) level |
M9 mitochondrial antibody (EIA) level |
M9 mitochondrial antibody (EIA) level |
MAG antibody level |
Measurement of myelin associated glycoprotein antibody (procedure) |
MB/total creatine kinase ratio |
Creatine kinase MB isoenzyme/total creatine kinase ratio measurement |
MB/total creatine kinase ratio |
Creatine kinase MB isoenzyme/total creatine kinase ratio measurement |
MCH - abnormal |
Mean corpuscular haemoglobin outside reference range |
MCH - low |
Mean corpuscular hemoglobin below reference range (finding) |
MCH - normal |
Mean corpuscular hemoglobin within reference range (finding) |
MCH - raised |
Mean corpuscular hemoglobin above reference range (finding) |
MCHC - low |
Mean corpuscular haemoglobin concentration below reference range |
MCHC - normal |
Mean corpuscular haemoglobin concentration within reference range |
MCHC - raised |
Mean corpuscular hemoglobin concentration above reference range |
MCV - low |
Mean corpuscular volume below reference range (finding) |
MCV - normal |
Mean corpuscular volume within reference range (finding) |
MCV - raised |
Mean corpuscular volume above reference range (finding) |
MMR not given |
Measles mumps and rubella vaccination not done (situation) |
MMR pre-school booster vaccination |
Administration of pre-school booster dose of vaccine product containing only Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens (procedure) |
MNS system antigen |
Antigen in MNS blood group system |
MRC Breathlessness Scale: grade 1 |
Medical Research Council Dyspnoea scale grade 1 (finding) |
MRC Breathlessness Scale: grade 1 |
Medical Research Council Dyspnoea scale grade 1 (finding) |
MRC Breathlessness Scale: grade 2 |
Medical Research Council Dyspnoea scale grade 2 (finding) |
MRC Breathlessness Scale: grade 2 |
Medical Research Council Dyspnoea scale grade 2 (finding) |
MRC Breathlessness Scale: grade 3 |
Medical Research Council Dyspnoea scale grade 3 (finding) |
MRC Breathlessness Scale: grade 3 |
Medical Research Council Dyspnoea scale grade 3 (finding) |
MRC Breathlessness Scale: grade 4 |
Medical Research Council Dyspnoea scale grade 4 (finding) |
MRC Breathlessness Scale: grade 4 |
Medical Research Council Dyspnoea scale grade 4 (finding) |
MRC Breathlessness Scale: grade 5 |
Medical Research Council Dyspnoea scale grade 5 (finding) |
MRC Breathlessness Scale: grade 5 |
Medical Research Council Dyspnoea scale grade 5 (finding) |
MRSA infection of postoperative wound |
MRSA infection of postoperative wound |
MS alpha-fetoprotein level |
MS alpha-fetoprotein level |
MS alpha-fetoprotein level |
MS alpha-fetoprotein level |
MSU = abnormal |
MSU = abnormal |
MSU = equivocal |
MSU = equivocal |
MSU = no abnormality |
MSU = no abnormality |